Loading chat...
IN HB1356
Bill
Status
1/12/2017
Primary Sponsor
Sue Errington
Click for details
AI Summary
HB 1356 Summary
-
Establishes a medical cannabis program allowing qualifying patients with written physician recommendations to use cannabis for designated conditions including cancer, glaucoma, HIV/AIDS, hepatitis C, ALS, Crohn's disease, Alzheimer's disease, multiple sclerosis, PTSD, and chronic pain or nausea.
-
Requires the state department of health to adopt rules by July 1, 2018 governing medical cannabis licensing, application processes, product safety standards, testing requirements, and cultivation limits of 90-day supply per patient.
-
Provides immunity from civil and criminal liability for physicians who recommend medical cannabis use based on a bona fide physician-patient relationship, excluding cases of gross negligence or willful misconduct.
-
Grants limited reciprocity to nonresident medical cannabis cardholders visiting Indiana for up to 30 days, allowing possession but not purchase of medical cannabis in the state.
-
Creates legal defenses to marijuana possession and drug paraphernalia charges for licensed patient cardholders, dispensaries, testing laboratories, manufacturing facilities, and medical cannabis agents acting within their authorized licenses.
Legislative Description
Medical cannabis. Defines "qualifying patient", and permits a qualifying patient to use medical cannabis under certain circumstances. Requires the state department of health to adopt rules before July 1, 2018, concerning the use, distribution, cultivation, production, and testing of medical cannabis. Provides limited reciprocity for holders of nonresident medical cannabis cards. Provides immunity from civil and criminal liability for physicians who recommend the medical use of cannabis. Provides a defense to: (1) arrest; and (2) criminal prosecution; for marijuana possession and use in certain circumstances. Makes conforming amendments.
Last Action
Representative Bartlett added as coauthor
2/2/2017